How many insider declarations has Carter Jason S filed?

Carter Jason S has filed 2 public insider declarations with SEC (Form 4).

What is Carter Jason S's role?

Carter Jason S's reported role is not specified by the regulator across the filings.

Which companies does Carter Jason S report trades for?

Carter Jason S reports trades for Vera Therapeutics, Inc..

What is Carter Jason S's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 93k€.

← Executives ★ Sign in to follow

CJ

Carter Jason S

OFFICER

·SEC (Form 4)

Vera Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€93,196

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Carter Jason S. Insider active across 1 company, notably Vera Therapeutics, Inc.. Aggregated, 2 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €93k. History available since 18 November 2024. The latest transaction was filed on 21 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Carter Jason S

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Vera Therapeutics, Inc. (US)

申报2 总计

▼

Carter Jason S

Chief Legal Officer高管2025年11月21日Vera Therapeutics, Inc.

US$107,49831SEC ↗

3,864 股@ US$27.8204100.0% 占其流量Class A Common StockSEC:0001193125-25-297161:0

◆

Carter Jason S

Chief Legal Officer高管2024年11月18日Vera Therapeutics, Inc.

0SEC ↗

53,000 股0Class A Common StockSEC:0001415889-24-027332:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CJ

Carter Jason S

OFFICER

·SEC (Form 4)

Vera Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€93,196

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Carter Jason S. Insider active across 1 company, notably Vera Therapeutics, Inc.. Aggregated, 2 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €93k. History available since 18 November 2024. The latest transaction was filed on 21 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.